Myda Advisors LLC Nuvation Bio Inc. Transaction History

Myda Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$4.6 - $8.83 $92,000 - $176,600	-20,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.75 - $10.05 $155,000 - $201,000	-20,000 Reduced 50.0%	20,000 $170,000
Q3 2021 Nov 12, 2021	SELL	$7.78 - $10.0 $46,680 - $60,000	-6,000 Reduced 13.04%	40,000 $398,000
Q2 2021 Aug 13, 2021	SELL	$9.22 - $14.48 $313,480 - $492,320	-34,000 Reduced 42.5%	46,000 $428,000
Q1 2021 May 12, 2021	BUY	$9.0 - $14.57 $720,000 - $1.17 Million	80,000 New	80,000 $836,000

159

157M

3.2K

98.7K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $587M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.